Cited by 202Cancer, Hypoxia, and MetabolismMetabolism, Diabetes, and CancerCancer, Lipids, and Metabolism

The DOI matches its Crossref record; 183 of the 186 references it cites were found in a registry or an index.

Targeting Cancer Metabolism: Dietary and Pharmacologic Interventions

Open access

Vernieri, Claudio, Casola, Stefano, Foiani, Marco, Pietrantonio, Filippo, de Braud, Filippo, Longo, Valter·2016·Cancer Discovery

DOI 10.1158/2159-8290.cd-16-0615PMC PMC5140697

Open this paper in CoChat — free account

Abstract

Most tumors display oncogene-driven reprogramming of several metabolic pathways, which are crucial to sustain their growth and proliferation. In recent years, both dietary and pharmacologic approaches that target deregulated tumor metabolism are beginning to be considered for clinical applications. Dietary interventions exploit the ability of nutrient-restricted conditions to exert broad biological effects, protecting normal cells, organs, and systems, while sensitizing a wide variety of cancer cells to cytotoxic therapies. On the other hand, drugs targeting enzymes or metabolites of crucial metabolic pathways can be highly specific and effective, but must be matched with a responsive tumor, which might rapidly adapt. In this review, we illustrate how dietary and pharmacologic therapies differ in their effect on tumor growth, proliferation, and metabolism and discuss the available preclinical and clinical evidence in favor of or against each of them. We also indicate, when appropriate, how to optimize future investigations on metabolic therapies on the basis of tumor- and patient-related characteristics. Significance: To our knowledge, this is the first review article that comprehensively analyzes the preclinical and preliminary clinical experimental foundations of both dietary and pharmacologic metabolic interventions in cancer therapy. Among several promising therapies, we propose treatment personalization on the basis of tumor genetics, tumor metabolism, and patient systemic metabolism.Cancer Discov; 6(12); 1315–33. ©2016 AACR.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1158/2159-8290.cd-16-0615

Cites

183 of 183 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197
mTOR Signaling in Growth Control and Disease
Laplante, M., & Sabatini, D. M. (2012) · Cell · doi:10.1016/j.cell.2012.03.017 · Cited by 8,509
Role of AMP-Activated Protein Kinase in Mechanism of Metformin Action
Zhou, G., Myers, R., Li, Y., Chen, Y., Shen, X., Fenyk-Melody, J., Wu, M., Ventre, J., Doebber, T., Fujii, N., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13505 · Cited by 5,652
Insulin-Like Growth Factors and Their Binding Proteins: Biological Actions*
Jones, J. I. W., & Clemmons, D. R. (1995) · Endocrine Reviews · doi:10.1210/edrv-16-1-3 · Cited by 4,488
HIF-1-mediated expression of pyruvate dehydrogenase kinase: A metabolic switch required for cellular adaptation to hypoxia
Kim, J.-W., Tchernyshyov, I., Semenza, G. L., & Dang, C. V. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.02.002 · Cited by 3,905
Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis
Menendez, J. A., & Lupu, R. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2222 · Cited by 2,941
Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites
Wikoff, W. R., Anfora, A. T., Liu, J., Schultz, P. G., Lesley, S. A., Peters, E. C., & Siuzdak, G. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0812874106 · Cited by 2,677
Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis
DeBerardinis, R. J., Mancuso, A., Daikhin, E., Nissim, I., Yudkoff, M., Wehrli, S., & Thompson, C. B. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709747104 · Cited by 2,622
mTOR Inhibition Induces Upstream Receptor Tyrosine Kinase Signaling and Activates Akt
O'Reilly, K. E., Rojo, F., She, Q.-B., Solit, D., Mills, G. B., Smith, D., Lane, H., Hofmann, F., Hicklin, D. J., Ludwig, D. L., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2925 · Cited by 2,561

Show all 186 references

Sorted by citations

Targeting cancer metabolism in the era of precision oncology
Stine, Z. E., Schug, Z. T., Salvino, J. M., & Dang, C. V. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00339-6 · Cited by 1,189
A GPX4-dependent cancer cell state underlies the clear-cell morphology and confers sensitivity to ferroptosis
Zou, Y., Palte, M. J., Deik, A. A., Li, H., Eaton, J. K., Wang, W., Tseng, Y.-Y., Deasy, R., Kost-Alimova, M., Dančík, V., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-09277-9 · Cited by 887
Palmitic Acid: Physiological Role, Metabolism and Nutritional Implications
Carta, G., Murru, E., Banni, S., & Manca, C. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00902 · Cited by 862
Metabolic Flexibility as an Adaptation to Energy Resources and Requirements in Health and Disease
Smith, R. L., Soeters, M. R., Wüst, R. C. I., & Houtkooper, R. H. (2018) · Endocrine Reviews · doi:10.1210/er.2017-00211 · Cited by 787
Metabolomics in cancer research and emerging applications in clinical oncology
Schmidt, D. R., Patel, R., Kirsch, D. G., Lewis, C. A., Heiden, M. G. V., & Locasale, J. W. (2021) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21670 · Cited by 675
Cancer Metabolism: Phenotype, Signaling and Therapeutic Targets
Park, J. H., Pyun, W. Y., & Park, H. W. (2020) · Cells · doi:10.3390/cells9102308 · Cited by 571
Anticancer effects of the microbiome and its products
Zitvogel, L., Daillère, R., Roberti, M. P., Routy, B., & Kroemer, G. (2017) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2017.44 · Cited by 538
Potential Mechanisms Connecting Purine Metabolism and Cancer Therapy
Yin, J., Ren, W., Huang, X., Deng, J., Li, T., & Yin, Y. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01697 · Cited by 462
Transferrin receptor 1 in cancer: a new sight for cancer therapy.
Shen, Y., Li, X., Dong, D., Zhang, B., Xue, Y., & Shang, P. (2018) · Europe PMC (PubMed Central) · Cited by 357
Systems Chronotherapeutics
Ballesta, A., Innominato, P. F., Dallmann, R., Rand, D. A. J., & Lévi, F. (2017) · Pharmacological Reviews · doi:10.1124/pr.116.013441 · Cited by 348
Warburg effect in colorectal cancer: the emerging roles in tumor microenvironment and therapeutic implications
Zhong, X., He, X., Wang, Y., Hu, Z., Huang, H., Zhao, S., Wei, P., & Li, D. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01358-5 · Cited by 356
Mitochondria and cancer chemoresistance
Guerra, F., Arbini, A., & Moro, L. (2017) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2017.01.012 · Cited by 331
Fasting-Mimicking Diet Is Safe and Reshapes Metabolism and Antitumor Immunity in Patients with Cancer
Vernieri, C., Fucà, G., Ligorio, F., Huber, V., Vingiani, A., Iannelli, F., Raimondi, A., Rinchai, D., Frigè, G., Belfiore, A., et al. (2022) · Cancer Discovery · doi:10.1158/2159-8290.cd-21-0030 · Cited by 319
Self-citation
Practical classification of triple-negative breast cancer: intratumoral heterogeneity, mechanisms of drug resistance, and novel therapies
Marra, A., Trapani, D., Viale, G., Criscitiello, C., & Curigliano, G. (2020) · npj Breast Cancer · doi:10.1038/s41523-020-00197-2 · Cited by 332
Reprogramming of the Tumor in the Hypoxic Niche: The Emerging Concept and Associated Therapeutic Strategies
Qiu, G., Jin, M., Dai, J., Sun, W., Feng, J., & Jin, W. (2017) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2017.05.002 · Cited by 250
RETRACTED ARTICLE: Fasting inhibits aerobic glycolysis and proliferation in colorectal cancer via the Fdft1-mediated AKT/mTOR/HIF1α pathway suppression
Weng, M.-L., Chen, W.-K., Chen, X.-Y., Lu, H., Sun, Z.-R., Yu, Q., Sun, P.-F., Xu, Y.-J., Zhu, M.-M., Jiang, N., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-15795-8 · Cited by 242
Retracted
Resistance mechanisms to anti-HER2 therapies in HER2-positive breast cancer: Current knowledge, new research directions and therapeutic perspectives
Vernieri, C., Milano, M., Brambilla, M., Mennitto, A., Maggi, C., Cona, M. S., Prisciandaro, M., Fabbroni, C., Celio, L., Mariani, G., et al. (2019) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2019.05.001 · Cited by 258
Self-citation
RORγ is a targetable master regulator of cholesterol biosynthesis in a cancer subtype
Cai, D., Wang, J., Gao, B., Li, J., Wu, F., Zou, J. X., Xu, J., Jiang, Y., Zou, H., Huang, Z., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-12529-3 · Cited by 167
Impact of cancer metabolism on therapy resistance – Clinical implications
Gonçalves, A. C., Richiardone, E., Jorge, J., Polónia, B. R. G., Xavier, C. P. R., Salaroglio, I. C., Riganti, C., Vasconcelos, M. H., Corbet, C., & Sarmento‐Ribeiro, A. B. (2021) · Drug Resistance Updates · doi:10.1016/j.drup.2021.100797 · Cited by 176
Starvation, Stress Resistance, and Cancer
Buono, R., & Longo, V. D. (2018) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2018.01.008 · Cited by 162
Self-citation
Targeting Metabolic–Redox Circuits for Cancer Therapy
Wang, K., Jiang, J., Lei, Y., Zhou, S., Wei, Y., & Huang, C. (2019) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2019.01.001 · Cited by 162
Curcumin decreases Warburg effect in cancer cells by down-regulating pyruvate kinase M2 via mTOR-HIF1α inhibition
Siddiqui, F. A., Prakasam, G., Chattopadhyay, S., Rehman, A. U., Padder, R. A., Ansari, M. A., Irshad, R., Mangalhara, K. C., Bamezai, R. N. K., Husain, M., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-25524-3 · Cited by 160
Butyrate Suppresses the Proliferation of Colorectal Cancer Cells via Targeting Pyruvate Kinase M2 and Metabolic Reprogramming
Li, Q., Cao, L., Tian, Y., Zhang, P., Ding, C., Lu, W., Jia, C., Shao, C., Liu, W., Wang, D., et al. (2018) · Molecular & Cellular Proteomics · doi:10.1074/mcp.ra118.000752 · Cited by 153
Cancer metabolism and carcinogenesis
Yang, J., Shay, C., Saba, N. F., & Teng, Y. (2024) · Experimental Hematology and Oncology · doi:10.1186/s40164-024-00482-x · Cited by 155
Long Noncoding RNA TINCR-Mediated Regulation of Acetyl-CoA Metabolism Promotes Nasopharyngeal Carcinoma Progression and Chemoresistance
Zheng, Z., Li, Z., Guan, J.-L., Liu, X., Li, J., Chen, Y., Lin, L. C., Kou, J., Lv, J., Zhang, L., et al. (2020) · Cancer Research · doi:10.1158/0008-5472.can-19-3626 · Cited by 126
The role of Wnt signaling pathway in tumor metabolic reprogramming
Mo, Y., Wang, Y., Zhang, L., Yang, L., Zhou, M., Li, X., Li, Y., Li, G., Zeng, Z., Xiong, W., et al. (2019) · Journal of Cancer · doi:10.7150/jca.31166 · Cited by 106
Inhibition of fatty acid catabolism augments the efficacy of oxaliplatin-based chemotherapy in gastrointestinal cancers
Wang, Y., Lu, J., Wang, F., Wang, Y., He, M.-M., Wu, Q., Lu, Y., Yu, H., Chen, Z., Zhao, Q., et al. (2020) · Cancer Letters · doi:10.1016/j.canlet.2019.12.036 · Cited by 106
Modulation of dysregulated cancer metabolism by plant secondary metabolites: A mechanistic review
Fakhri, S., Moradi, S. Z., Farzaei, M. H., & Bishayee, A. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.02.007 · Cited by 97
MicroRNAs in Tumor Cell Metabolism: Roles and Therapeutic Opportunities
Pedroza‐Torres, A., Romero-Cordoba, S. L., Justo-Garrido, M., Salido-Guadarrama, I., Rodríguez‐Bautista, R., Montaño, S., Muñiz-Mendoza, R., Arriaga-Canon, C., Fragoso‐Ontiveros, V., Álvarez-Gómez, R. M., et al. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.01404 · Cited by 93
Metformin Use Is Associated With Longer Progression-Free Survival of Patients With Diabetes and Pancreatic Neuroendocrine Tumors Receiving Everolimus and/or Somatostatin Analogues
Pusceddu, S., Vernieri, C., Maïo, M. D., Marconcini, R., Spada, F., Massironi, S., Ibrahim, T., Brizzi, M. P., Campana, D., Faggiano, A., et al. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.04.010 · Cited by 89
Self-citation
Caregiver Well-being and the Quality of Cancer Care
Litzelman, K. (2019) · Seminars in Oncology Nursing · doi:10.1016/j.soncn.2019.06.006 · Cited by 96
Silibinin induces metabolic crisis in triple‐negative breast cancer cells by modulating EGFR‐MYC‐TXNIP axis: potential therapeutic implications
Iqbal, M. A., Chattopadhyay, S., Siddiqui, F. A., Rehman, A. U., Siddiqui, S. I., Prakasam, G., Khan, A., Sultana, S., & Bamezai, R. N. K. (2020) · FEBS Journal · doi:10.1111/febs.15353 · Cited by 85
Butyrate enhances the efficacy of radiotherapy via FOXO3A in colorectal cancer patient‑derived organoids
Park, M., Kwon, J., Shin, H., Moon, S., Kim, S. W., Shin, U. S., Han, Y., & Kim, Y. (2020) · International Journal of Oncology · doi:10.3892/ijo.2020.5132 · Cited by 84
Targeting Glucose Metabolism to Enhance Immunotherapy: Emerging Evidence on Intermittent Fasting and Calorie Restriction Mimetics
Turbitt, W. J., Demark‐Wahnefried, W., Peterson, C. M., & Norian, L. A. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01402 · Cited by 87
Bioinformatics Analysis and Validation of Potential Markers Associated with Prediction and Prognosis of Gastric Cancer
Matsuoka, T., & Yashiro, M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25115880 · Cited by 83
“Commonly, cancer metabolism has a significant role in the tumorigenesis, progression, as well as drug resistance of cancer [55].”
Background
Computational approaches to modelling and optimizing cancer treatment
McDonald, T. O., Cheng, Y.-C., Graser, C. J., Nicol, P. B., Temko, D., & Michor, F. (2023) · Nature Reviews Bioengineering · doi:10.1038/s44222-023-00089-7 · Cited by 83
Reprogramming of Amino Acid Metabolism in Pancreatic Cancer: Recent Advances and Therapeutic Strategies
Xu, R., Yang, J., Ren, B., Wang, H., Yang, G., Chen, Y., You, L., & Zhao, Y. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.572722 · Cited by 74
Targeting Pyruvate Carboxylase by a Small Molecule Suppresses Breast Cancer Progression
Lin, Q., He, Y., Wang, X., Zhang, Y., Hu, M., Guo, W., He, Y., Zhang, T., Lai, L., Sun, Z., et al. (2020) · Advanced Science · doi:10.1002/advs.201903483 · Cited by 71
Pathogenesis and therapeutic strategy in platinum resistance lung cancer
Lv, P., Man, S., Xie, L., Ma, L., & Gao, W. (2021) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2021.188577 · Cited by 74
Obesity and Cancer Metabolism: A Perspective on Interacting Tumor–Intrinsic and Extrinsic Factors
Doerstling, S. S., O’Flanagan, C. H., & Hursting, S. D. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00216 · Cited by 68
Targeting Cancer Metabolism to Resensitize Chemotherapy: Potential Development of Cancer Chemosensitizers from Traditional Chinese Medicines
Guo, W., Tan, H., Chen, F., Wang, N., & Feng, Y. (2020) · Cancers · doi:10.3390/cancers12020404 · Cited by 65
Fasting improves therapeutic response in hepatocellular carcinoma through p53-dependent metabolic synergism
Krstic, J., Reinisch, I., Schindlmaier, K., Galhuber, M., Riahi, Z., Berger, N., Kupper, N., Moyschewitz, E., Auer, M., Michenthaler, H., et al. (2022) · Science Advances · doi:10.1126/sciadv.abh2635 · Cited by 64
Deciphering metabolic rewiring in breast cancer subtypes
Ogrodzinski, M. P., Bernard, J. J., & Lunt, S. Y. (2017) · Translational research · doi:10.1016/j.trsl.2017.07.004 · Cited by 67
Diet and supplements in cancer prevention and treatment: Clinical evidences and future perspectives
Vernieri, C., Nichetti, F., Raimondi, A., Pusceddu, S., Platania, M., Berrino, F., & de Braud, F. (2018) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2018.01.002 · Cited by 65
Self-citation
Fasting inhibits hepatic stellate cells activation and potentiates anti‐cancer activity of Sorafenib in hepatocellular cancer cells
Re, O. L., Panebianco, C., Porto, S., Cervi, C., Rappa, F., Biase, S. D., Caraglia, M., Pazienza, V., & Vinciguerra, M. (2017) · Journal of Cellular Physiology · doi:10.1002/jcp.25987 · Cited by 59
Citrate Promotes Excessive Lipid Biosynthesis and Senescence in Tumor Cells for Tumor Therapy
Zhao, Y., Liu, X., Si, F., Huang, L., Gao, A., Lin, W., Hoft, D. F., Shao, Q., & Peng, G. (2021) · Advanced Science · doi:10.1002/advs.202101553 · Cited by 59
Thymidine kinase 1 drives hepatocellular carcinoma in enzyme-dependent and -independent manners
Li, Q., Zhang, L., Yang, Q., Li, M., Pan, X., Xu, J., Zhong, C., Yao, F., Zhang, R., Zhou, S., et al. (2023) · Cell Metabolism · doi:10.1016/j.cmet.2023.03.017 · Cited by 57
Polymorphism rs1761667 in the CD36 Gene Is Associated to Changes in Fatty Acid Metabolism and Circulating Endocannabinoid Levels Distinctively in Normal Weight and Obese Subjects
Melis, M., Carta, G., Pintus, S., Pintus, P., Piras, C. A., Murru, E., Manca, C., Marzo, V. D., Banni, S., & Barbarossa, I. T. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.01006 · Cited by 56
PARylated PDHE1α generates acetyl-CoA for local chromatin acetylation and DNA damage repair
Zhang, J., Chen, F., Tian, Y., Xu, W., Zhu, Q., Li, Z., Qiu, L., Lu, X., Peng, B., Liu, X., et al. (2023) · Nature Structural & Molecular Biology · doi:10.1038/s41594-023-01107-3 · Cited by 54
Cyclic fasting-mimicking diet in cancer treatment: Preclinical and clinical evidence
Vernieri, C., Ligorio, F., Tripathy, D., & Longo, V. D. (2024) · Cell Metabolism · doi:10.1016/j.cmet.2024.06.014 · Cited by 57
Self-citation
Everolimus versus alpelisib in advanced hormone receptor-positive HER2-negative breast cancer: targeting different nodes of the PI3K/AKT/mTORC1 pathway with different clinical implications
Vernieri, C., Corti, F., Nichetti, F., Ligorio, F., Manglaviti, S., Zattarin, E., Rea, C. G., Capri, G., Bianchi, G., & de Braud, F. (2020) · Breast Cancer Research · doi:10.1186/s13058-020-01271-0 · Cited by 51
Self-citation
Targeting lipid metabolism is an emerging strategy to enhance the efficacy of anti-HER2 therapies in HER2-positive breast cancer
Ligorio, F., Pellegrini, I., Castagnoli, L., Vingiani, A., Lobefaro, R., Zattarin, E., Santamaria, M., Pupa, S. M., Pruneri, G., de Braud, F., et al. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.04.023 · Cited by 49
Self-citation
Impact of systemic and tumor lipid metabolism on everolimus efficacy in advanced pancreatic neuroendocrine tumors (pNETs)
Vernieri, C., Pusceddu, S., Fucà, G., Indelicato, P., Centonze, G., Castagnoli, L., Ferrari, E., Ajazi, A., Pupa, S. M., Casola, S. S., et al. (2018) · International Journal of Cancer · doi:10.1002/ijc.32042 · Cited by 46
Self-citation
Metabolomics at the tumor microenvironment interface: Decoding cellular conversations
Berrell, N., Sadeghirad, H., Blick, T., Bidgood, C. L., Leggatt, G. R., O'Byrne, K. J., & Kulasinghe, A. (2023) · Medicinal Research Reviews · doi:10.1002/med.22010 · Cited by 44
Co-occurring KRAS mutation/LKB1 loss in non-small cell lung cancer cells results in enhanced metabolic activity susceptible to caloric restriction: an in vitro integrated multilevel approach
Caiola, E., Falcetta, F., Giordano, S., Marabese, M., Garassino, M. C., Broggini, M., Pastorelli, R., & Brunelli, L. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0954-5 · Cited by 41
The Adaptive Complexity of Cancer
Derbal, Y. (2018) · BioMed Research International · doi:10.1155/2018/5837235 · Cited by 41
mTORC2 links growth factor signaling with epigenetic regulation of iron metabolism in glioblastoma
Masui, K., Harachi, M., Ikegami, S., Yang, H., Onizuka, H., Yong, W. H., Cloughesy, T. F., Muragaki, Y., Kawamata, T., Arai, N., et al. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.011519 · Cited by 38
Targeting glutamine utilization to block metabolic adaptation of tumor cells under the stress of carboxyamidotriazole-induced nutrients unavailability
Shi, J., Jü, R., Gao, H., Huang, Y., Guo, L., & Zhang, D. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.07.008 · Cited by 37
Impact of Metformin Use and Diabetic Status During Adjuvant Fluoropyrimidine-Oxaliplatin Chemotherapy on the Outcome of Patients with Resected Colon Cancer: A TOSCA Study Subanalysis
Vernieri, C., Galli, F., Ferrari, L., Marchetti, P., Lonardi, S., Maiello, E., Iaffaioli, R. V., Zampino, M. G., Zaniboni, A., Placido, S. D., et al. (2019) · The Oncologist · doi:10.1634/theoncologist.2018-0442 · Cited by 36
Self-citation
Molecular docking of anti-inflammatory drug diclofenac with metabolic targets: Potential applications in cancer therapeutics
Pandey, S. K., Yadav, S., Goel, Y., Temre, M. K., Singh, V. K., & Singh, S. M. (2019) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2019.01.020 · Cited by 36
Probing metabolic alterations in breast cancer in response to molecular inhibitors with Raman spectroscopy and validated with mass spectrometry
Wen, X., Ou, Y., Bogatcheva, G. T., Thomas, G., Mahadevan-Jansen, A. M., Singh, B., Lin, E. C., & Bardhan, R. (2020) · Chemical Science · doi:10.1039/d0sc02221g · Cited by 34
Fasting in oncology: a word of caution
Caccialanza, R., Aprile, G., Cereda, E., & Pedrazzoli, P. (2019) · Nature reviews. Cancer · doi:10.1038/s41568-018-0098-0 · Cited by 34
The Obesity-Related Gut Bacterial and Viral Dysbiosis Can Impact the Risk of Colon Cancer Development
Campisciano, G., de Manzini, N., Delbue, S., Cason, C., Cosola, D., Basile, G., Ferrante, P., Comar, M., & Palmisano, S. (2020) · Microorganisms · doi:10.3390/microorganisms8030431 · Cited by 34
Physciosporin suppresses mitochondrial respiration, aerobic glycolysis, and tumorigenesis in breast cancer
Taş, İ., Varlı, M., Son, Y., Han, J., Kwak, D., Yang, Y., Zhou, R., Gamage, C. D. B., Pulat, S., Park, S., et al. (2021) · Phytomedicine · doi:10.1016/j.phymed.2021.153674 · Cited by 34
Cancer-associated fibroblast-derived extracellular vesicles: regulators and therapeutic targets in the tumor microenvironment
Xie, J.-D., Lin, X.-M., Deng, X.-P., Tang, H.-L., Zou, Y.-T., Chen, W., & Xie, X.-M. (2025) · Cancer Drug Resistance · doi:10.20517/cdr.2024.152 · Cited by 56
Cholesterol suppresses GOLM1-dependent selective autophagy of RTKs in hepatocellular carcinoma
Shao, W., Zhu, W., Luo, M.-J., Fan, M.-H., Li, Q., Wang, S., Lin, Z., Zhao, J., Zheng, Y., Dong, Q., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110712 · Cited by 33
Metabolic Reprogramming by Reduced Calorie Intake or Pharmacological Caloric Restriction Mimetics for Improved Cancer Immunotherapy
Eriau, E., Paillet, J., Kroemer, G., & Pol, J. G. (2021) · Cancers · doi:10.3390/cancers13061260 · Cited by 31
Polymer-Drug Conjugates: Novel Carriers for Cancer Chemotherapy
Seifu, M. F., & Nath, L. K. (2018) · Polymer-Plastics Technology and Materials · doi:10.1080/03602559.2018.1466172 · Cited by 31
Disruptor of telomeric silencing 1-like promotes ovarian cancer tumor growth by stimulating pro-tumorigenic metabolic pathways and blocking apoptosis
Chava, S., Wajapeyee, N., Edwards, Y. J. K., & Gupta, R. (2021) · Oncogenesis · doi:10.1038/s41389-021-00339-6 · Cited by 31
Metabolic markers for diagnosis and risk-prediction of multiple myeloma
Fei, F., Ma, T., Zhou, X., Zheng, M., Cao, B., & Li, J. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118852 · Cited by 30
How Far Are We from Prescribing Fasting as Anticancer Medicine?
Deligiorgi, M. V., Liapi, C. A., & Trafalis, D. T. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21239175 · Cited by 32
Combination of Baseline LDH, Performance Status and Age as Integrated Algorithm to Identify Solid Tumor Patients with Higher Probability of Response to Anti PD-1 and PD-L1 Monoclonal Antibodies
Cona, M. S., Lecchi, M., Cresta, S., Damian, S., Vecchio, M. D., Necchi, A., Poggi, M. M., Raggi, D., Randon, G., Ratta, R., et al. (2019) · Cancers · doi:10.3390/cancers11020223 · Cited by 28
Self-citation
Nutritional Epigenetics in Cancer
Barrero, M. J., Cejas, P., Long, H. W., & de Molina, A. R. (2022) · Advances in Nutrition · doi:10.1093/advances/nmac039 · Cited by 27
Shining a light on metabolic vulnerabilities in non-small cell lung cancer
Dowling, C. M., Zhang, H., Chonghaile, T. N., & Wong, K.-K. (2021) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2020.188462 · Cited by 26
“Energy is generated inside the cell through the metabolism of carbon molecules in a series of catabolic reactions, while anabolic reactions enable the biosynthesis of complex biomolecules [1].”
Background
Identification of HER2-positive breast cancer molecular subtypes with potential clinical implications in the ALTTO clinical trial
Rediti, M., Venet, D., Garcia, A. J., Maetens, M., Vincent, D., Majjaj, S., El-Abed, S., Cosimo, S. D., Ueno, T., Izquierdo, M. A., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-54621-3 · Cited by 27
Natural Products and Altered Metabolism in Cancer: Therapeutic Targets and Mechanisms of Action
Talib, W. H., Baban, M. M., Bulbul, M. F., Al-Zaidaneen, E., Allan, A., Al-Rousan, E. W., Ahmad, R. H. Y., Alshaeri, H. K., Alasmari, M. M., & Law, D. S. N. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25179593 · Cited by 25
Targeting cancer metabolic vulnerabilities for advanced therapeutic efficacy
Muluh, T. A., Shu, X., & Ying, Y. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114658 · Cited by 26
Identification of Cancer–associated metabolic vulnerabilities by modeling multi-objective optimality in metabolism
Dai, Z., Xu, L., Xu, L., Liao, K., Deng, S., Chen, Q., Wang, Q., Wang, Q., Gao, S., Li, B., et al. (2019) · Cell Communication and Signaling · doi:10.1186/s12964-019-0439-y · Cited by 26
A review of the literature on the use of CRISPR/Cas9 gene therapy to treat hepatocellular carcinoma
Amjad, E., Pezzani, R., & Sokouti, B. (2024) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.32604/or.2023.044473 · Cited by 26
Cholesterol-Induced Metabolic Reprogramming in Breast Cancer Cells Is Mediated via the ERRα Pathway
Ghanbari, F., Fortier, A.-M., Park, M., & Philip, A. (2021) · Cancers · doi:10.3390/cancers13112605 · Cited by 23
Metabolic disorders and gastroenteropancreatic-neuroendocrine tumors (GEP-NETs): How do they influence each other? An Italian Association of Medical Oncology (AIOM)/ Italian Association of Medical Diabetologists (AMD)/ Italian Society of Endocrinology (SIE)/ Italian Society of Pharmacology (SIF) multidisciplinary consensus position paper
Natalicchio, A., Faggiano, A., Zatelli, M. C., Argentiero, A., D’Oronzo, S., Marrano, N., Beretta, G. D., Acquati, S., Adinolfi, V., Bartolo, P. D., et al. (2021) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2021.103572 · Cited by 24
Dietary Manipulation of Amino Acids for Cancer Therapy
Jiménez‐Alonso, J. J., & López‐Lázaro, M. (2023) · Nutrients · doi:10.3390/nu15132879 · Cited by 26
L-arginine/5-fluorouracil combination treatment approaches cells selectively: Rescuing endothelial cells while killing MDA-MB-468 breast cancer cells
Jahani, M., Azadbakht, M., Rasouli, H., Yarani, R., Rezazadeh, D., Salari, N., & Mansouri, K. (2018) · Food and Chemical Toxicology · doi:10.1016/j.fct.2018.11.018 · Cited by 24
Serum metabolic profiling enables diagnosis, prognosis, and monitoring for brainstem gliomas
Li, K., Wang, R., Gu, Z., Weng, W., Liu, W., Huang, Y., Wu, J., Zhang, Z., Yang, S., Su, J., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-61163-9 · Cited by 23
Emodin, as a mitochondrial uncoupler, induces strong decreases in adenosine triphosphate (ATP) levels and proliferation of B16F10 cells, owing to their poor glycolytic reserve
Sugiyama, Y., Shudo, T., Hosokawa, S., Watanabe, A., Nakano, M., & Kakizuka, A. (2019) · Genes to Cells · doi:10.1111/gtc.12712 · Cited by 21
The Influence of Modifiable Factors on Breast and Prostate Cancer Risk and Disease Progression
Tan, K., & Naylor, M. J. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.840826 · Cited by 23
Emerging insights into mechanisms of trastuzumab resistance in HER2-positive cancers
Wu, X., Huang, S., He, W., & Song, M. L. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.110602 · Cited by 23
The emerging role of deubiquitylating enzymes as therapeutic targets in cancer metabolism
Tu, R., Ma, J., Zhang, P., Kang, Y., Xiong, X., Zhu, J., Li, M., & Zhang, C. (2022) · Cancer Cell International · doi:10.1186/s12935-022-02524-y · Cited by 24
KITENIN promotes aerobic glycolysis through PKM2 induction by upregulating the c-Myc/hnRNPs axis in colorectal cancer
Varlı, M., Kim, S. J., Noh, M., Kim, Y. G., Ha, H., Kim, K. K., & Kim, H. (2023) · Cell & Bioscience · doi:10.1186/s13578-023-01089-1 · Cited by 19
Metabolic vulnerabilities in cancer: A new therapeutic strategy
El‐Tanani, M., Rabbani, S. A., El‐Tanani, Y., & Matalka, I. I. (2024) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2024.104438 · Cited by 20
Phosphorylation of E‐box binding USF‐1 by PI3K/AKT enhances its transcriptional activation of the WBP2 oncogene in breast cancer cells
Ramos, A., Miow, Q. H., Xu, L., Lin, Q. S., Putti, T. C., & Lim, Y. P. (2018) · The FASEB Journal · doi:10.1096/fj.201801167rr · Cited by 19
Amino acid deprivation triggers a novel GCN2-independent response leading to the transcriptional reactivation of non-native DNA sequences
Vito, A. D., Lazzaro, M., Palmisano, I., Cittaro, D., Riba, M., Lazarevic, D., Bannai, M., Gabellini, D., & Schiaffino, M. V. (2018) · PLoS ONE · doi:10.1371/journal.pone.0200783 · Cited by 16
m1A methylation modification patterns and metabolic characteristics in hepatocellular carcinoma
Tong, C.-C., Wang, W., & He, C. (2022) · BMC Gastroenterology · doi:10.1186/s12876-022-02160-w · Cited by 18
The Clinical Value of Lipid Abnormalities in Early Stage Cervical Cancer
Jiang, Q., Wang, L., Jin, M., Shou, Y., Zhu, H., & Li, A. (2022) · International Journal of General Medicine · doi:10.2147/ijgm.s352934 · Cited by 17
Prediction of Metabolic Profiles from Transcriptomics Data in Human Cancer Cell Lines
Cavicchioli, M. V., Santorsola, M., Balboni, N., Mercatelli, D., & Giorgi, F. M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073867 · Cited by 16
Medicinal Plants for the Treatment of Gastrointestinal Cancers From the Metabolomics Perspective
Guo, W., Cao, P., Wang, X., Hu, M., & Feng, Y. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.909755 · Cited by 16
Stratifying nutritional restriction in cancer therapy: Next stop, personalized medicine
Krstić, J., Pieber, T. R., & Prokesch, A. (2020) · International review of cytology · doi:10.1016/bs.ircmb.2020.03.001 · Cited by 18
Metabolic orchestration of T lineage differentiation and function
Yong, C. S. M., Moussa, D. A., Cretenet, G., Kinet, S., Dardalhon, V., & Taylor, N. N. (2017) · FEBS Letters · doi:10.1002/1873-3468.12849 · Cited by 16
Thermodynamic Genome-Scale Metabolic Modeling of Metallodrug Resistance in Colorectal Cancer
Herrmann, H. A., Rusz, M., Baier, D., Jakupec, M. A., Keppler, B. K., Berger, W., Koellensperger, G., & Zanghellini, J. (2021) · Cancers · doi:10.3390/cancers13164130 · Cited by 15
CD36 enrichment in HER2-positive mesenchymal stem cells drives therapy refractoriness in breast cancer
Castagnoli, L., Franceschini, A., Cancila, V., Dugo, M., Bigliardi, M., Chiodoni, C., Toneguzzo, P., Regondi, V., Corsetto, P. A., Pietrantonio, F., et al. (2025) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-025-03276-z · Cited by 15
Self-citation

Authors: Vernieri, C., Casola, S., Foiani, M., Pietrantonio, F., de Braud, F., & Longo, V.
Affiliations: IFOM (IT)
University of Milan (IT)
Fondazione IRCCS Istituto Nazionale dei Tumori (IT)
University of Southern California (US)
Corresponding author: Vernieri, Claudio
Longo, Valter
ORCID: Vernieri, Claudio
Casola, Stefano
Foiani, Marco
Pietrantonio, Filippo
de Braud, Filippo
Longo, Valter
Venue: Cancer Discovery
Publisher: American Association for Cancer Research (AACR)
Published: 2016-12-01
Volume: 6
Issue: 12
Pages: 1315-1333
ISSN: 2159-8274 (ISSN-L)
2159-8290
DOI: 10.1158/2159-8290.cd-16-0615
PMC: PMC5140697
OpenAlex: W2554098255
Cited by: 202
References: 186
Citations by year: 2026: 16 · 2025: 21 · 2024: 22 · 2023: 18 · 2022: 20 · 2021: 24 · 2020: 28 · 2019: 20 · 2018: 21 · 2017: 12
FWCI: 1.62
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Locations: Cancer Discovery (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) (submittedVersion, other-oa)
Funders: National Institute on Aging (P01AG034906)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
Keywords: cancer metabolism, tumor metabolic reprogramming, dietary intervention, nutrient restriction, metabolic therapy, personalized treatment, cancer genetics, drug resistance
MeSH terms: Antineoplastic Agents, Cell Survival, Combined Modality Therapy, Diet Therapy, Humans, Neoplasms, Cell Proliferation, Metabolic Networks and Pathways, Precision Medicine

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Targeting Cancer Metabolism: Dietary and Pharmacologic Interventions

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks